Cannabix Technologies Inc. entered into a strategic partnership and development agreement dated May 15, 2024 (the ?Agreement?) with Omega Laboratories Inc. of Ohio, USA (?Omega Laboratories? or ?Omega?). The Agreement provides a pathway for commercialization of Cannabix?s marijuana breathalyzer technology.

Pursuant to the Agreement, Cannabix and Omega Laboratories (together, the ?Parties?) have agreed to, among other things, complete research and development, refine and expand the use of Cannabix?s technology to meet existing and emerging needs of Omega?s clients, contemplate manufacturing and distribution and introduce the delta9 THC breath testing technology to customers in North America.